Physician profile
Arash Jalil
NPI 1326686015
$564.41
in general payments reported to CMS, 2019-2025
9 companies · $216 in 2025
The $216 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $19.67 · 2023: $17.57 · 2024: $311 · 2025: $216.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $545.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $544.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $222.51 | 2023-2025 | Nuzyra |
| Organogenesis INC. | $101.27 | 2024-2025 | Puraply Wound Matrix, Puraply Franchise |
| Integra Lifesciences Corporation | $63.50 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Smith+Nephew, INC. | $46.59 | 2024-2025 | Regranex, Collagenase Santyl |
| Linvatec Corporation | $29.88 | 2025 | Biobrace 23mm |
| Bioventus LLC | $29.81 | 2024 | Exogen Ultrasound Bone Healing System |
| Djo, LLC | $28.67 | 2025 | Aircast |
| Amgen INC. | $26.33 | 2024 | Krystexxa |
| Saxum Surgical, INC. | $15.85 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arash Jalil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.